onr:"swepub:oai:DiVA.org:uu-329916"
Search: onr:"swepub:oai:DiVA.org:uu-329916" > High expression of ...
- 1 of 1
- Previous record
- Next record
- To hitlist
- Ahlin, CeciliaÖrebro University (author)
High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers
- Article/chapterEnglish2017
Publisher, publication year, extent ...
- 2017-05-20
- SPRINGER,2017
- electronicrdacarrier
Numbers
- LIBRIS-ID:oai:DiVA.org:uu-329916
- https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-329916URI
- https://doi.org/10.1007/s10549-017-4294-5DOI
- https://lup.lub.lu.se/record/c3220b9d-b86a-4280-a2d8-7f7e257fc64dURI
Supplementary language notes
- Language:English
- Summary in:English
Part of subdatabase
- SwePubSwePub
Classification
Notes
- Cyclin D1 has a central role in cell cycle control and is an important component of estrogen regulation of cell cycle progression. We have previously shown that high cyclin D expression is related to aggressive features of ER-positive but not ER-negative breast cancer. The aims of the present study were to validate this differential ER-related effect and furthermore explore the relationship between cyclin D overexpression and CCND1 gene amplification status in a node-negative breast cancer case-control study. Immunohistochemical nuclear expression of cyclin D1 (n = 364) and amplification of the gene CCND1 by fluorescent in situ hybridization (n = 255) was performed on tissue microarray sections from patients with T1-2N0M0 breast cancer. Patients given adjuvant chemotherapy were excluded. The primary event was defined as breast cancer death. Breast cancer-specific survival was analyzed in univariate and multivariable models using conditional logistic regression. Expression of cyclin D1 above the median (61.7%) in ER breast cancer was associated with an increased risk for breast cancer death (OR 3.2 95% CI 1.5-6.8) also when adjusted for tumor size and grade (OR 3.1). No significant prognostic impact of cyclin D1 expression was found among ER-negative cases. Cyclin D1 overexpression was significantly associated to high expression of the proliferation markers cyclins A (rho 0.19, p = 0.006) and B (rho 0.18, p = 0.003) in ER-positive tumors, but not in ER-negative cases. There was a significant association between CCND1 amplification and cyclin D1 expression (p = 0.003), but CCND1 amplification was not statistically significantly prognostic (HR 1.4, 95% CI 0.4-4.4). We confirmed our previous observation that high cyclin D1 expression is associated to high proliferation and a threefold higher risk of death from breast cancer in ER-positive breast cancer.
Subject headings and genre
- MEDICIN OCH HÄLSOVETENSKAP Klinisk medicin Cancer och onkologi hsv//swe
- MEDICAL AND HEALTH SCIENCES Clinical Medicine Cancer and Oncology hsv//eng
- Breast cancer
- Proliferation
- Cyclin D1
- CCND1
- Breast cancer
- CCND1
- Cyclin D1
- Proliferation
Added entries (persons, corporate bodies, meetings, titles ...)
- Lundgren, Claudia,1966-Uppsala University,Uppsala universitet,Experimentell och klinisk onkologi(Swepub:uu)clalu702 (author)
- Embretsen-Varro, ElinÖrebro University (author)
- Jirström, KarinLund University,Lunds universitet,Tumörmikromiljö,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Tumor microenvironment,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine(Swepub:lu)pat-kji (author)
- Blomqvist, CarlÖrebro University,University of Helsinki (author)
- Fjällskog, Marie-LouiseUppsala University,Uppsala universitet,Onkologisk endokrinologi(Swepub:uu)marifjal (author)
- Örebro UniversityExperimentell och klinisk onkologi (creator_code:org_t)
Related titles
- In:Breast Cancer Research and Treatment: SPRINGER164:3, s. 667-6780167-68061573-7217
Internet link
- https://doi.org/10.1007/s10549-017-4294-5Fulltext
- https://uu.diva-portal.org/smash/get/diva2:1184905/FULLTEXT01.pdffulltext:print
- https://link.springer.com/content/pdf/10.1007%2Fs10549-017-4294-5.pdf
- http://dx.doi.org/10.1007/s10549-017-4294-5FULLTEXT
- https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-329916
- https://doi.org/10.1007/s10549-017-4294-5
- https://lup.lub.lu.se/record/c3220b9d-b86a-4280-a2d8-7f7e257fc64d
Find in a library
- Breast Cancer Research and Treatment (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Ahlin, Cecilia
- Lundgren, Claudi ...
- Embretsen-Varro, ...
- Jirström, Karin
- Blomqvist, Carl
- Fjällskog, Marie ...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Clinical Medicin ...
- and Cancer and Oncol ...
- Articles in the publication
- Breast Cancer Re ...
- By the university
- Uppsala University
- Lund University
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
